Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

NCT04539327

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Hospital Torrecárdenas Almería, Andalusia, Spain
  • Hospital Universitario Virgen de la Victoria Málaga, Andalusia, Spain
  • Hospital Universitario Virgen del Rocío Seville, Andalusia, Spain
  • Hospital Universitario Nuestra Señora de Valme Seville, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

NCT05198804

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Arizona Oncology Associates (Wilmot HOPE) - USOR Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 22 locations
View Trial Details
Completed

Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

NCT05041257

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope National Medical Center /ID# 269928 Duarte, California, United States
  • University of California Los Angeles /ID# 269969 Los Angeles, California, United States
  • University Colorado Cancer Center /ID# 269930 Aurora, Colorado, United States
  • Women'S Cancer Care /ID# 269925 Covington, Louisiana, United States
View all 35 locations
View Trial Details
Completed

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

NCT06173037

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 30 locations
View Trial Details
Completed

Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

NCT05483933

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations
  • University of Arkansas for Medical sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 21 locations
View Trial Details
Completed

A Trial Evaluating TG4050 in Ovarian Carcinoma.

NCT03839524

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Institut Curie Paris, France
View Trial Details

Related conditions